Adjuvant Cemiplimab or Placebo in High-Risk Cutaneous Squamous-Cell Carcinoma

Danny Rischin

Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia

Sandro Porceddu

Department of Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia

Fiona Day

Department of Medical Oncology, Calvary Mater Newcastle, Waratah, NSW, Australia

Daniel P. Brungs

Illawarra Cancer Care Centre, Wollongong Hospital, Wollongong, NSW, Australia

Hayden Christie

Cancer Care Centre Hervey Bay, Urraween, QLD, Australia

James E. Jackson

Radiation Oncology Centers, Gold Coast, QLD, Australia

Brian N. Stein

Adelaide Cancer Centre, Adelaide, SA, Australia

Yungpo Bernard Su

Head and Neck Medical Oncology, Nebraska Cancer Specialists, Omaha

Rahul Ladwa

Princess Alexandra Hospital, Woolloongabba, QLD, Australia

Gerard Adams

Radiation Oncology, Genesis Care, Bundaberg, QLD, Australia

Samantha E. Bowyer

Department of Medical Oncology, Sir Charles Gairdner Hospital, Perth, WA, Australia

Zulfiquer Otty

Townsville Cancer Centre, Townsville University Hospital, Townsville, QLD, Australia

Naoya Yamazaki

National Cancer Center Hospital, Tokyo

Paolo Bossi

Department of Biomedical Sciences, Humanitas University, Milan

Amarnath Challapalli

Bristol Cancer Institute, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, United Kingdom

Axel Hauschild

Department of Dermatology, University Hospital, Kiel, Germany

Annette M. Lim

Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia

Vishal A. Patel

George Washington University School of Medicine and Health Sciences, Washington, DC

Joanna L. Walker

Department of Dermatology, Hospital of the University of Pennsylvania, Philadelphia

Maite De Liz Vassen Schurmann

Animi Oncology Treatment Unit, University Planalto Catarinense, Lages, Brazil

Paola Queirolo

Melanoma and Sarcoma Division, European Institute of Oncology, IRCCS, Milan

Javier Cañueto

Department of Dermatology, Complejo Asistencial Universitario de Salamanca, Salamanca, Spain

Flavio Augusto Ferreira da Silva

Department of Clinical Oncology, Hospital de Amor Barretos, São Paulo

Alexander Stratigos

First Department of Dermatology–Venereology, University of Athens Medical School, Andreas Sygros Hospital, Athens

Alexander Guminski

Department of Medical Oncology, Royal North Shore Hospital, St. Leonards, NSW, Australia

Charles Lin

Department of Radiation Oncology, Royal Brisbane and Women’s Hospital, Herston, QLD, Australia

Fernanda Damian

Centro de Pesquisa em Oncologia, Hospital São Lucas, Pontifical Catholic University of Rio Grande do Sul, Porto Alegre, Brazil

Lukas Flatz

University Hospital Tübingen, Tübingen, Germany

Anne E. Taylor

Central Adelaide Local Health Network, Royal Adelaide Hospital, Adelaide, SA, Australia

David R. Carr

Department of Dermatology, Ohio State University Medical Center, Columbus

Samuel Harris

Bendigo Cancer Centre, Bendigo Health, Bendigo, VIC, Australia

Dmitry Kirtbaya

State Budgetary Institution of Healthcare, Oncology Dispensary No. 2, Ministry of Healthcare of Krasnodar Region, Sochi, Russia

Gaëlle Quereux

Dermatology Department, Nantes University, Centre Hospitalier Universitaire Nantes, Centre d’Investigation Clinique 1413, Immunologie et Nouveaux Concepts en Immunothérapie, Unité Mixte de Recherche 1302, Nantes, France

Piotr Rutkowski

Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland

Nicole Basset-Seguin

Hôpital Saint Louis, Assistance Publique–Hôpitaux de Paris, Paris

Nikhil I. Khushalani

Caroline Robert

Haisong Ju

Regeneron Pharmaceuticals, Tarrytown, NY

Camryn Joseph

Regeneron Pharmaceuticals, Tarrytown, NY

Shikha Bansal

Regeneron Pharmaceuticals, Tarrytown, NY

Chieh-I Chen

Regeneron Pharmaceuticals, Tarrytown, NY

Frank Seebach

Regeneron Pharmaceuticals, Tarrytown, NY

Suk-Young Yoo

Regeneron Pharmaceuticals, Tarrytown, NY

Israel Lowy

Regeneron Pharmaceuticals, Tarrytown, NY

Priscila Goncalves

Regeneron Pharmaceuticals, Tarrytown, NY

Matthew G. Fury

Regeneron Pharmaceuticals, Tarrytown, NY